Mason J. Belue

Mason J. Belue

Auto-generated profile, based on publicly available information

Mason J. Belue

Department of Urology, University of Arkansas for Medical Sciences, Little Rock, Arkansas

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2023 in Radiology
Verified
Journal Article
Closed access
EYEnis C Yilmaz
Enis C Yilmaz
JSJoanna H. Shih
Joanna H. Shih
MBMason J. Belue
Mason J. Belue
SHStephanie Harmon
Stephanie Harmon
TPTim E. Phelps
Tim E. Phelps
BTBaris Turkbey
Baris Turkbey
Background Data regarding the prospective performance of Prostate Imaging Reporting and Data System (PI-RADS) version 2.1 alone and in combination with quantitative MRI features for prostate cancer detection is limited. Purpose To assess lesion-based clinically significant prostate cancer (csPCa) rates in different PI-RADS version 2.1 categories and to identify MRI features that could improve csPCa detection. Materials and Methods This single-center prospective study included men with suspected or known prostate cancer who underwent multiparametric MRI and MRI/US-guided biopsy from April 2019 to December 2021. MRI scans were prospectively evaluated using PI-RADS version 2.1. Atypical transition zone (TZ) nodules were upgraded to category 3 if marked diffusion restriction was present. Lesions with an International Society of Urological Pathology (ISUP) grade of 2 or higher (range, 1-5) were considered csPCa. MRI features, including three-dimensional diameter, relative lesion volume (lesion volume divided by prostate volume), sphericity, and surface to volume ratio (SVR), were obtained from lesion contours delineated by the radiologist. Univariable and multivariable analyses were conducted at the lesion and participant levels to determine features associated with csPCa. Results In total, 454 men (median age, 67 years [IQR, 62-73 years]) with 838 lesions were included. The csPCa rates for lesions categorized as PI-RADS 1 (n = 3), 2 (n = 170), 3 (n = 197), 4 (n = 319), and 5 (n = 149) were 0%, 9%, 14%, 37%, and 77%, respectively. csPCa rates of PI-RADS 4 lesions were lower than PI-RADS 5 lesions (P < .001) but higher than PI-RADS 3 lesions (P < .001). Upgraded PI-RADS 3 TZ lesions were less likely to harbor csPCa compared with their nonupgraded counterparts (4% [one of 26] vs 20% [20 of 99], P = .02). Predictors of csPCa included relative lesion volume (odds ratio [OR], 1.6; P < .001), SVR (OR, 6.2; P = .02), and extraprostatic extension (EPE) scores of 2 (OR, 9.3; P < .001) and 3 (OR, 4.1; P = .02). Conclusion The rates of csPCa differed between consecutive PI-RADS categories of 3 and higher. MRI features, including lesion volume, shape, and EPE scores of 2 and 3, predicted csPCa. Upgrading of PI-RADS category 3 TZ lesions may result in unnecessary biopsies. ClinicalTrials.gov registration no. NCT03354416 © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Goh in this issue.

1 May 2024 in Radiology
Verified
Journal Article
Closed access
YLYue Lin
Yue Lin
EYEnis C Yilmaz
Enis C Yilmaz
MBMason J. Belue
Mason J. Belue
SHStephanie Harmon
Stephanie Harmon
JTJesse Tetreault
Jesse Tetreault
BTBaris Turkbey
Baris Turkbey
A deep learning–based algorithm automatically detected cancerous lesions on prostate biparametric MRI scans with reasonable performance and reliably predicted clinically significant prostate cancer at biopsy.

22 January 2024 in Academic Radiology
Verified
Journal Article
Closed access
MBMason J. Belue
Mason J. Belue
SHStephanie Harmon
Stephanie Harmon
DYDong Yang
Dong Yang
JAJulie Y. An
Julie Y. An
SGSonia Gaur
Sonia Gaur
BTBaris Turkbey
Baris Turkbey

1 November 2024 in Radiology: Imaging Cancer
Verified
Journal Article
Closed access
EYEnis C Yilmaz
Enis C Yilmaz
SHStephanie Harmon
Stephanie Harmon
YLYan Mee Law
Yan Mee Law
EHErich P. Huang
Erich P. Huang
MBMason J. Belue
Mason J. Belue
BTBaris Turkbey
Baris Turkbey
Purpose To evaluate the performance of an artificial intelligence (AI) model in detecting overall and clinically significant prostate cancer (csPCa)-positive lesions on paired external and in-house biparametric MRI (bpMRI) scans and assess performance differences between each dataset. Materials and Methods This single-center retrospective study included patients who underwent prostate MRI at an external institution and were rescanned at the authors' institution between May 2015 and May 2022. A genitourinary radiologist performed prospective readouts on in-house MRI scans following the Prostate Imaging Reporting and Data System (PI-RADS) version 2.0 or 2.1 and retrospective image quality assessments for all scans. A subgroup of patients underwent an MRI/US fusion-guided biopsy. A bpMRI-based lesion detection AI model previously developed using a completely separate dataset was tested on both MRI datasets. Detection rates were compared between external and in-house datasets with use of the paired comparison permutation tests. Factors associated with AI detection performance were assessed using multivariable generalized mixed-effects models, incorporating features selected through forward stepwise regression based on the Akaike information criterion. Results The study included 201 male patients (median age, 66 years [IQR, 62-70 years]; prostate-specific antigen density, 0.14 ng/mL2 [IQR, 0.10-0.22 ng/mL2]) with a median interval between external and in-house MRI scans of 182 days (IQR, 97-383 days). For intraprostatic lesions, AI detected 39.7% (149 of 375) on external and 56.0% (210 of 375) on in-house MRI scans (P < .001). For csPCa-positive lesions, AI detected 61% (54 of 89) on external and 79% (70 of 89) on in-house MRI scans (P < .001). On external MRI scans, better overall lesion detection was associated with a higher PI-RADS score (odds ratio [OR] = 1.57; P = .005), larger lesion diameter (OR = 3.96; P < .001), better diffusion-weighted MRI quality (OR = 1.53; P = .02), and fewer lesions at MRI (OR = 0.78; P = .045). Better csPCa detection was associated with a shorter MRI interval between external and in-house scans (OR = 0.58; P = .03) and larger lesion size (OR = 10.19; P < .001). Conclusion The AI model exhibited modest performance in identifying both overall and csPCa-positive lesions on external bpMRI scans. Keywords: MR Imaging, Urinary, Prostate Supplemental material is available for this article. © RSNA, 2024.

11 April 2025 in Academic Radiology
Verified
Journal Article
Closed access
MBMason J. Belue
Mason J. Belue
VMVaneeza Mukhtar
Vaneeza Mukhtar
RRRoopa Ram
Roopa Ram
NGNeriman Gokden
Neriman Gokden
JJJoe Jose
Joe Jose
AAAhmet Murat Aydin
Ahmet Murat Aydin

25 August 2023 in The Prostate
Verified
Journal Article
Closed access
MBMason J. Belue
Mason J. Belue
ZBZoë Blake
Zoë Blake
EYEnis C Yilmaz
Enis C Yilmaz
YLYue Lin
Yue Lin
SHStephanie Harmon
Stephanie Harmon
PPPeter A. Pinto
Peter A. Pinto